Compare Amylx Pharmaceuticals Inc (AMLX) vs Burlington Stores Inc (BURL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Burlington Stores Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.66 (market cap $2.64B), while Burlington Stores Inc trades at $353.95 (market cap $22.59B). The key difference: Burlington Stores Inc is far larger — about 8.6× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Burlington Stores Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | BURL | |
|---|---|---|
Market Cap | $2.64B | $22.59B |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $372.19 |
52-Week Low | $7.82 | $242.43 |
Enterprise Value | $2.39B | $27.71B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Burlington Stores Inc
Burlington is a leading off-price retailer in the US, offering branded apparel, footwear, and home goods at significant discounts. It operates hundreds of stores focused on delivering high-quality products at great value.
Read more on BURL →
